CG Oncology (CGON) Change in Account Payables (2023 - 2026)
CG Oncology (CGON) posted Change in Account Payables of $2.5 million for Q1 2026, up 172.49% on a QoQ basis from -$3.5 million in Q4 2025, and up 1078.5% year-over-year from $214000.0 in Q1 2025.
CG Oncology (CGON) Change in Account Payables (2023 - 2026) Analysis & Trends
CG Oncology's Change in Account Payables history runs 4 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- Quarterly Change in Account Payables rose 1078.5% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $664000.0 (down 67.95% YoY) and the FY2025 annual result came in at -$1.6 million, down 150.2% from the prior year.
- Change in Account Payables was $2.5 million for Q1 2026 at CG Oncology, up from -$3.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.5 million in Q1 2026 and bottomed at -$3.5 million in Q4 2025.
- A 4-year average of $474230.8 and a median of $394000.0 in 2025 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 15844.44% in 2024, while the deepest fall reached 442.86% in 2024.
- CG Oncology's Change in Account Payables stood at $1.4 million in 2023, then jumped by 76.63% to $2.4 million in 2024, then sank by 242.52% to -$3.5 million in 2025, then soared by 172.49% to $2.5 million in 2026.
- Business Quant data shows CGON's Change in Account Payables at $2.5 million in Q1 2026, -$3.5 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | 2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.52 Mn |
| Mar 31, 2026 | 2.52 Mn |
| Dec 31, 2025 | -3.48 Mn |
| Dec 31, 2025 | -3.48 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 394,000.00 |
| Jun 30, 2025 | 394,000.00 |
| Mar 31, 2025 | 214,000.00 |
| Mar 31, 2025 | 214,000.00 |
| Dec 31, 2024 | 2.44 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | -415,000.00 |
| Sep 30, 2024 | -415,000.00 |
| Jun 30, 2024 | -168,000.00 |
| Jun 30, 2024 | -168,000.00 |
| Mar 31, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Dec 31, 2023 | 1.38 Mn |